Active Ingredients and Mechanism of Action of Rhizoma Coptidis against Type 2 Diabetes Based on Network-Pharmacology and Bioinformatics

Abstract

A pharmacological network of “component/target/pathway” for Rhizoma coptidis against type 2 diabetes (T2D) was established by network-pharmacology, and the active components of Rhizoma coptidis and its mechanism were explored. A literature-based and database study of the components of Rhizoma coptidis was carried out and screened by ADME parameters. The targets of Rhizoma coptidis were predicted by the ligand similarity method. Related pathways were analyzed with databases, and software was used to construct a “component/target/path” network. The mechanism was further confirmed by GEO database with R software. A total of 12 active components were screened from Rhizoma coptidis, involving 57 targets including MAPK1, STAT3, INSR, and 38 signaling pathways were associated with T2D. Related signaling pathways included essential pathways for T2D such as insulin resistance, and pathways that had indirect effect on T2D. It was suggested that Rhizoma coptidis may exert its effects against T2D through multi-component, multi-target, and multi-pathway forms.

Keywords

network pharmacology / Rhizoma coptidis / type 2 diabetes / traditional Chinese medicine / bioinformatics

References

[1] TangJ, FengY, TsaoS, et al.. Berberine and Coptidis Rhizoma as novel antineoplastic agents: A review of traditional use and biomedical investigations. J Ethnopharmacol, 2009, 126(1): 5-17

[2] MengFC, WuZF, YinZQ, et al.. Coptidis rhizoma and its main bioactive components: recent advances in chemical investigation, quality evaluation and pharmacological activity. Chin Med, 2018, 13(1): 13

[3] JaacksLM, SiegelKR, GujralUP, et al.. Type 2 diabetes: A 21st century epidemic. Best Pract Res Clin Endocrinol Metab, 2016, 30(3): 331-343

[4] TongXL, DongL, ChenL, et al.. Treatment of Diabetes Using Traditional Chinese Medicine: Past, Present and Future. Am J Chin Med, 2012, 40(05): 877-886

[5] WangH, MuW, ShangH, et al.. The antihyperglycemic effects of Rhizoma Coptidis and mechanism of actions: a review of systematic reviews and pharmacological research. BioMed Res Int, 2014, 2014: 98093

[6] ZhaoX, FengA, HuangQ, et al.. Effect of Rhizoma Coptidis on Bax and Bcl-2 Protein Expression in Diabetic Rats with Cerebral Ischemia Reperfusion. Pract Geriat, 2017, 31(11): 1021-1024

[7] LeeYS, KimWS, KimKH, et al.. Berberine, a Natural Plant Product, Activates AMP-Activated Protein Kinase with Beneficial Metabolic Effects in Diabetic and Insulin-Resistant States. Diabetes, 2006, 55(8): 2256

[8] XiaX, YanJ, ShenY, et al.. Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis. PLoS One, 2011, 6(2): e16556

[9] LuSS, YuYL, ZhuHJ, et al.. Berberine promotes glucagon-like peptide-1 (7–36) amide secretion in streptozotocin-induced diabetic rats. J Endocrinol, 2009, 200(2): 159-165

[10] HopkinsAL. Network pharmacology. Nature Biotechnol, 2007, 25: 1110

[11] HopkinsAL. Network pharmacology: the next paradigm in drug discovery. Nature Chem Biol, 2008, 4: 682

[12] LiS, ZhangB. Traditional Chinese medicine network pharmacology: theory, methodology and application. Chin J Natural Med, 2013, 11(2): 110-120

[13] LiFS, WengJK. Demystifying traditional herbal medicine with modern approach. Nature Plants, 2017, 3: 17 109

[14] BarnesJ. Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part I. Regulation and quality. Br J Clin Pharmacol, 2003, 55(3): 226-233

[15] GuJ, GuiY, ChenL, et al.. Use of Natural Products as Chemical Library for Drug Discovery and Network Pharmacology. PLoS One, 2013, 8(4): e62839

[16] YiF, LiL, XuLJ, et al.. In silico approach in reveal traditional medicine plants pharmacological material basis. Chin Med, 2018, 13(1): 33

[17] HuangWY, DongH. Coptidis Rhizoma-Contained Traditional Formulae for Insomnia: A Potential to Prevent Diabetes?. Chin J Integr Med, 2018, 24(10): 785-788